Michael A. Whitt - Publications

Affiliations: 
Cancer and Developmental Biology University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Virology Biology, Microbiology Biology

66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wohlgemuth N, Whitt K, Cherry S, Kirkpatrick Roubidoux E, Lin CY, Allison KJ, Gowen A, Freiden P, Allen EK, Gaur AH, Estepp JH, Tang L, Mori T, Hijano DR, ... ... Whitt MA, et al. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization. Microbiology Spectrum. e0105921. PMID 34704832 DOI: 10.1128/Spectrum.01059-21  0.393
2021 Stelitano D, Weisberg SP, Goldklang MP, Zhu Y, Bovier FT, Kalantarov GF, Greco G, Decimo D, Franci G, Cennamo M, Portella G, Galdiero M, Mathieu C, Horvat B, Trakht IN, ... ... Whitt MA, et al. Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals. Msphere. e0057121. PMID 34319126 DOI: 10.1128/mSphere.00571-21  0.373
2020 Condor Capcha JM, Lambert G, Dykxhoorn DM, Salerno AG, Hare JM, Whitt MA, Pahwa S, Jayaweera DT, Shehadeh LA. Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine. 7: 618651. PMID 33521067 DOI: 10.3389/fcvm.2020.618651  0.356
2020 McAndrews KM, Dowlatshahi DP, Dai J, Becker LM, Hensel J, Snowden LM, Leveille JM, Brunner MR, Holden K, Hopkins NS, Harris A, Kumpati JJ, Whitt MA, Lee JJ, Ostrosky-Zeichner L, et al. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity. Jci Insight. PMID 32796155 DOI: 10.1172/Jci.Insight.142386  0.344
2019 Lester S, Harcourt J, Whitt M, Al-Abdely HM, Midgley CM, Alkhamis AM, Aziz Jokhdar HA, Assiri AM, Tamin A, Thornburg N. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies. Access Microbiology. 1: e000057. PMID 32974558 DOI: 10.1099/acmi.0.000057  0.308
2019 Lester S, Harcourt J, Whitt M, Al-Abdely HM, Midgley CM, Alkhamis AM, Aziz Jokhdar HA, Assiri AM, Tamin A, Thornburg N. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies Access Microbiology. 1. DOI: 10.1099/acmi.0.000057  0.361
2016 Whitt MA, Geisbert TW, Mire CE. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses. Methods in Molecular Biology (Clifton, N.J.). 1403: 295-311. PMID 27076138 DOI: 10.1007/978-1-4939-3387-7_16  0.73
2016 Cox JV, Kansal R, Whitt MA. Rab43 Regulates the Sorting of a Subset of Membrane Protein Cargo through the Medial Golgi. Molecular Biology of the Cell. PMID 27053659 DOI: 10.1091/Mbc.E15-03-0123  0.344
2015 Whitt MA, Cox ME, Kansal R, Cox JV. Kinetically distinct sorting pathways through the Golgi exhibit different requirements for Arf1. Traffic (Copenhagen, Denmark). 16: 267-83. PMID 25470762 DOI: 10.1111/Tra.12248  0.327
2013 Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virology Journal. 10: 353. PMID 24330654 DOI: 10.1186/1743-422X-10-353  0.671
2012 Du Z, Whitt MA, Baumann J, Garner JM, Morton CL, Davidoff AM, Pfeffer LM. Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 32: 368-77. PMID 22509977 DOI: 10.1089/Jir.2012.0002  0.397
2012 Talekar A, Pessi A, Glickman F, Sengupta U, Briese T, Whitt MA, Mathieu C, Horvat B, Moscona A, Porotto M. Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment Plos One. 7. PMID 22396728 DOI: 10.1371/Journal.Pone.0030538  0.437
2012 Moseley NB, Laur O, Ibegbu CC, Loria GD, Ikwuenzunma G, Jayakar HR, Whitt MA, Altman JD. Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cells. Journal of Immunological Methods. 375: 118-28. PMID 22004852 DOI: 10.1016/J.Jim.2011.09.016  0.777
2011 Whitt MA, Mire CE. Utilization of fluorescently-labeled tetracysteine-tagged proteins to study virus entry by live cell microscopy. Methods (San Diego, Calif.). 55: 127-36. PMID 21939769 DOI: 10.1016/J.Ymeth.2011.09.002  0.721
2011 Mire CE, Whitt MA. The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation. Virology. 416: 16-25. PMID 21596416 DOI: 10.1016/J.Virol.2011.04.013  0.757
2010 Whitt MA. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. Journal of Virological Methods. 169: 365-74. PMID 20709108 DOI: 10.1016/J.Jviromet.2010.08.006  0.565
2010 Mire CE, White JM, Whitt MA. A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. Plos Pathogens. 6: e1000994. PMID 20657818 DOI: 10.1371/Journal.Ppat.1000994  0.692
2010 Chang G, Xu S, Watanabe M, Jayakar HR, Whitt MA, Gingrich JR. Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer. The Journal of Urology. 183: 1611-8. PMID 20172545 DOI: 10.1016/J.Juro.2009.12.005  0.783
2009 Mire CE, Dube D, Delos SE, White JM, Whitt MA. Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. Journal of Virology. 83: 12139-50. PMID 19776119 DOI: 10.1128/Jvi.00955-09  0.675
2009 Porotto M, Orefice G, Yokoyama CC, Mungall BA, Realubit R, Sganga ML, Aljofan M, Whitt M, Glickman F, Moscona A. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy Journal of Virology. 83: 5148-5155. PMID 19264786 DOI: 10.1128/Jvi.00164-09  0.406
2007 Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, Mungall BA, Moscona A. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors Journal of Virology. 81: 10567-10574. PMID 17652384 DOI: 10.1128/Jvi.01181-07  0.383
2007 Dorsey FC, Muthusamy T, Whitt MA, Cox JV. A novel role for a YXXPhi motif in directing the caveolin-dependent sorting of membrane-spanning proteins. Journal of Cell Science. 120: 2544-54. PMID 17623779 DOI: 10.1242/Jcs.002493  0.325
2007 Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. Journal of Virology. 81: 8601-12. PMID 17553880 DOI: 10.1128/Jvi.00608-07  0.462
2007 Perez M, Clemente R, Robison CS, Jeetendra E, Jayakar HR, Whitt MA, de la Torre JC. Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. Journal of Virology. 81: 5527-36. PMID 17376911 DOI: 10.1128/Jvi.02586-06  0.798
2006 Klas SD, Lavine CL, Whitt MA, Miller MA. IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors. Vaccine. 24: 1451-61. PMID 16310294 DOI: 10.1016/J.Vaccine.2005.05.046  0.407
2005 Wilkins C, Dishongh R, Moore SC, Whitt MA, Chow M, Machaca K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature. 436: 1044-7. PMID 16107852 DOI: 10.1038/Nature03957  0.422
2004 Jayakar HR, Jeetendra E, Whitt MA. Rhabdovirus assembly and budding. Virus Research. 106: 117-32. PMID 15567492 DOI: 10.1016/J.Virusres.2004.08.009  0.776
2004 Pinschewer DD, Perez M, Jeetendra E, Bächi T, Horvath E, Hengartner H, Whitt MA, de la Torre JC, Zinkernagel RM. Kinetics of protective antibodies are determined by the viral surface antigen. The Journal of Clinical Investigation. 114: 988-93. PMID 15467838 DOI: 10.1172/Jci200422374  0.512
2004 Irie T, Licata JM, Jayakar HR, Whitt MA, Bell P, Harty RN. Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein. Journal of Virology. 78: 7823-7. PMID 15220457 DOI: 10.1128/Jvi.78.14.7823-7827.2004  0.782
2004 Duntsch CD, Zhou Q, Jayakar HR, Weimar JD, Robertson JH, Pfeffer LM, Wang L, Xiang Z, Whitt MA. Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model. Journal of Neurosurgery. 100: 1049-59. PMID 15200120 DOI: 10.3171/Jns.2004.100.6.1049  0.768
2004 Miller MA, Lavine CL, Klas SD, Pfeffer LM, Whitt MA. Recombinant replication-restricted VSV as an expression vector for murine cytokines. Protein Expression and Purification. 33: 92-103. PMID 14680966 DOI: 10.1016/J.Pep.2003.08.008  0.524
2003 Jeetendra E, Ghosh K, Odell D, Li J, Ghosh HP, Whitt MA. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. Journal of Virology. 77: 12807-18. PMID 14610202 DOI: 10.1128/Jvi.77.23.12807-12818.2003  0.539
2002 Klas SD, Robison CS, Whitt MA, Miller MA. Adjuvanticity of an IL-12 fusion protein expressed by recombinant deltaG-vesicular stomatitis virus. Cellular Immunology. 218: 59-73. PMID 12470614 DOI: 10.1016/S0008-8749(02)00575-0  0.341
2002 Jeetendra E, Robison CS, Albritton LM, Whitt MA. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. Journal of Virology. 76: 12300-11. PMID 12414970 DOI: 10.1128/Jvi.76.23.12300-12311.2002  0.576
2002 Neumann G, Whitt MA, Kawaoka Y. A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? The Journal of General Virology. 83: 2635-62. PMID 12388800 DOI: 10.1099/0022-1317-83-11-2635  0.482
2002 Jayakar HR, Whitt MA. Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. Journal of Virology. 76: 8011-8. PMID 12134006 DOI: 10.1128/Jvi.76.16.8011-8018.2002  0.778
2001 Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. Journal of Virology. 75: 10623-9. PMID 11602704 DOI: 10.1128/Jvi.75.22.10623-10629.2001  0.803
2001 He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nature Structural Biology. 8: 874-8. PMID 11573093 DOI: 10.1038/Nsb1001-874  0.349
2001 Matsuura Y, Tani H, Suzuki K, Kimura-Someya T, Suzuki R, Aizaki H, Ishii K, Moriishi K, Robison CS, Whitt MA, Miyamura T. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology. 286: 263-75. PMID 11485395 DOI: 10.1006/Viro.2001.0971  0.417
2001 Perez M, Watanabe M, Whitt MA, De la Torre JC. N-terminal domain of borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry Journal of Virology. 75: 7078-7085. PMID 11435588 DOI: 10.1128/Jvi.75.15.7078-7085.2001  0.505
2000 Jayakar HR, Murti KG, Whitt MA. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. Journal of Virology. 74: 9818-27. PMID 11024108 DOI: 10.1128/Jvi.74.21.9818-9827.2000  0.816
2000 Robison CS, Whitt MA. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly Journal of Virology. 74: 2239-2246. PMID 10666254 DOI: 10.1128/Jvi.74.5.2239-2246.2000  0.521
1999 Ito H, Watanabe S, Sanchez A, Whitt MA, Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein Journal of Virology. 73: 8907-8912. PMID 10482652 DOI: 10.1128/Jvi.73.10.8907-8912.1999  0.506
1999 Stillman EA, Whitt MA. Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription Journal of Virology. 73: 7199-7209. PMID 10438807 DOI: 10.1128/Jvi.73.9.7199-7209.1999  0.395
1998 Stillman EA, Whitt MA. The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation Journal of Virology. 72: 5565-5572. PMID 9621014 DOI: 10.1128/Jvi.72.7.5565-5572.1998  0.319
1998 Fredericksen BL, Whitt MA. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high Ph threshold for membrane fusion in viral fitness Virology. 240: 349-358. PMID 9454708 DOI: 10.1006/Viro.1997.8921  0.535
1998 Whitt MA. Genetic manipulation of rhabdoviruses: New insights to virus replication, transcription and assembly Journal of Microbiology. 36: 1-8.  0.338
1997 Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein Proceedings of the National Academy of Sciences of the United States of America. 94: 14764-14769. PMID 9405687 DOI: 10.1073/Pnas.94.26.14764  0.593
1997 Stillman EA, Whitt MA. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts Journal of Virology. 71: 2127-2137. PMID 9032346 DOI: 10.1128/Jvi.71.3.2127-2137.1997  0.372
1996 Schnell MJ, Buonocore L, Whitt MA, Rose JK. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. Journal of Virology. 70: 2318-23. PMID 8642658 DOI: 10.1128/Jvi.70.4.2318-2323.1996  0.435
1996 Kretzschmar E, Peluso R, Schnell MJ, Whitt MA, Rose JK. Normal replication of vesicular stomatitis virus without C proteins. Virology. 216: 309-16. PMID 8607260 DOI: 10.1006/Viro.1996.0066  0.519
1996 Fredericksen BL, Whitt MA. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion Virology. 217: 49-57. PMID 8599235 DOI: 10.1006/Viro.1996.0092  0.476
1995 Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, Grosveld G, Nienhuis AW. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Therapy. 6: 1203-13. PMID 8527479 DOI: 10.1089/Hum.1995.6.9-1203  0.456
1995 Fredericksen BL, Whitt MA. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity Journal of Virology. 69: 1435-1443. PMID 7853475 DOI: 10.1128/Jvi.69.3.1435-1443.1995  0.467
1995 Lawson ND, Stillman EA, Whitt MA, Rose JK. Recombinant vesicular stomatitis viruses from DNA. Proceedings of the National Academy of Sciences of the United States of America. 92: 4477-81. PMID 7753828 DOI: 10.1073/Pnas.92.10.4477  0.456
1995 Stillman EA, Rose JK, Whitt MA. Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. Journal of Virology. 69: 2946-53. PMID 7707520 DOI: 10.1128/Jvi.69.5.2946-2953.1995  0.545
1995 Lawson ND, Stillman EA, Whitt MA, Rose JK. Corrections: Recombinant Vesicular Stomatitis Viruses from DNA Proceedings of the National Academy of Sciences of the United States of America. 92: 9009. DOI: 10.1073/Pnas.92.19.9009C  0.355
1991 Whitt MA, Rose JK. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions. Virology. 185: 875-8. PMID 1660205 DOI: 10.1016/0042-6822(91)90563-Q  0.481
1991 Whitt MA, Buonocore L, Prehaud C, Rose JK. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology. 185: 681-8. PMID 1660200 DOI: 10.1016/0042-6822(91)90539-N  0.515
1990 Whitt MA, Zagouras P, Crise B, Rose JK. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. Journal of Virology. 64: 4907-13. PMID 2168975 DOI: 10.1128/Jvi.64.10.4907-4913.1990  0.539
1989 Whitt MA, Chong L, Rose JK. Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. Journal of Virology. 63: 3569-78. PMID 2547986 DOI: 10.1128/Jvi.63.9.3569-3578.1989  0.503
1988 Whitt MA, Manning JS. A phosphorylated 34-kDa protein and a subpopulation of polyhedrin are thiol linked to the carbohydrate layer surrounding a baculovirus occlusion body Virology. 163: 33-42. PMID 3279702 DOI: 10.1016/0042-6822(88)90231-0  0.3
1988 Whitt M, Doms R, Ruusala A, Helenius J, Helenius A, Rose J. Dual roles for the cytoplasmic domain of the VSV G protein: Protein transport and virus assembly Virus Research. 11: 6. DOI: 10.1016/0168-1702(88)90108-6  0.41
1988 Whitt MA, Manning JS. Stabilization of the Autographa californica nuclear polyhedrosis virus occlusion body matrix by zinc chloride Journal of Invertebrate Pathology. 51: 278-280. DOI: 10.1016/0022-2011(88)90035-3  0.411
1988 Whitt MA, Doms RW, Ruusala A, Helenius J, Helenius A, Rose JK. Dual roles for the cytoplasmic domain of the VSV G protein: Protein transport and virus assembly Virus Research. 11: 6.  0.41
1987 Whitt MA, Manning JS. Role of chelating agents, monovalent anion and cation in the dissociation of Autographa californica nuclear polyhedrosis virus occlusion body Journal of Invertebrate Pathology. 49: 61-69. DOI: 10.1016/0022-2011(87)90126-1  0.343
Show low-probability matches.